Benproperine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Benproperine is an antitussive indicated in the treatment of acute and dry cough, especially dry cough.

Generic Name
Benproperine
DrugBank Accession Number
DB13309
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 309.453
Monoisotopic: 309.209264493
Chemical Formula
C21H27NO
Synonyms
  • Bemproperina
  • Benproperine
  • Benproperinum

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Treatment ofChronic cough (cc)••••••••••••••••••• ••••••
Treatment ofCough, acute••••••••••••••••••• ••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Product Ingredients
IngredientUNIICASInChI Key
Benproperine phosphateS831Z48C5W3563-76-6MCVUURBOSHQXMK-UHFFFAOYSA-N
International/Other Brands
Cofrel / Pirexyl

Categories

ATC Codes
R05DB02 — Benproperine
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Diphenylmethanes
Direct Parent
Diphenylmethanes
Alternative Parents
Phenoxy compounds / Phenol ethers / Alkyl aryl ethers / Piperidines / Trialkylamines / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivatives
Substituents
Alkyl aryl ether / Amine / Aromatic heteromonocyclic compound / Azacycle / Diphenylmethane / Ether / Hydrocarbon derivative / Organic nitrogen compound / Organic oxygen compound / Organoheterocyclic compound
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
3AA6IZ48YK
CAS number
2156-27-6
InChI Key
JTUQXGZRVLWBCR-UHFFFAOYSA-N
InChI
InChI=1S/C21H27NO/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3
IUPAC Name
1-[1-(2-benzylphenoxy)propan-2-yl]piperidine
SMILES
CC(COC1=CC=CC=C1CC1=CC=CC=C1)N1CCCCC1

References

General References
  1. DIMDI Drug Product Information: Tussafug (benproperine phosphate) coated tablets [Link]
ChemSpider
2236
RxNav
236749
ChEBI
94380
ChEMBL
CHEMBL2105910
Wikipedia
Benproperine

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, coatedOral25 mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00143 mg/mLALOGPS
logP4.9ALOGPS
logP5.19Chemaxon
logS-5.3ALOGPS
pKa (Strongest Basic)9.05Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area12.47 Å2Chemaxon
Rotatable Bond Count6Chemaxon
Refractivity96.84 m3·mol-1Chemaxon
Polarizability36.75 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterYesChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-01qc-9830000000-4f35de4be6f4136af8d5
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-03di-0009000000-c51852a5c0c778ca8340
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-03di-0209000000-42ab4ecc1f5325283407
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-004i-5902000000-ee6937268e126c92d45d
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-005c-9600000000-f3c7590d078f40b900d8
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-000x-9400000000-ecde0e06639c0c7dfea4
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-000x-9300000000-c669606334ffc9648c70
MS/MS Spectrum - , positiveLC-MS/MSsplash10-03di-0309000000-ab87705b2c4d837ec7e8
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-2934000000-fdaffdba5f2997e3d675
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-05fr-0925000000-21aee0107a9b208cdb14
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-053r-1902000000-ff41fc5b6eb6be7dd548
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-03di-7749000000-50f641018563ab016304
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a59-1922000000-bfc44cd0fff96c6c75a9
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014j-9400000000-9362a8af7c1e0c31727b
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-171.82297
predicted
DeepCCS 1.0 (2019)
[M+H]+174.18098
predicted
DeepCCS 1.0 (2019)
[M+Na]+180.27412
predicted
DeepCCS 1.0 (2019)

Drug created at June 23, 2017 20:39 / Updated at June 02, 2021 20:03